The impact of bone tumours on clinical practice remains as large today as it was at the turn of the century and as it is likely to remain so for several decades more. Bone and soft tissue cancers create challenges for patients that are not seen in most other malignancies, such as changes in gait, function, stability, strength, and appearance. Moreover, the economic burden can be great: the more advanced the disease at diagnosis, the worse the prognosis and, accordingly, the more expensive the treatments. This chapter of the White Book on Tumours aims to present an impartial review and a comprehensive overview of the current healthcare situation for patients with bone tumours in Europe.
Copyright The Editor(s) (if applicable) and The Author(s) 2021. This book is an Open-Access-Publication.